Subtopic Deep Dive

← Peroxisome Proliferator-Activated Receptors

PPARs in Inflammation and Macrophage Polarization
Research Guide

What is PPARs in Inflammation and Macrophage Polarization?

PPARs, particularly PPARα, PPARδ, and PPARγ, suppress pro-inflammatory cytokine production and promote M2 macrophage polarization in inflammatory conditions like atherosclerosis and obesity through negative cross-talk with NF-κB signaling.

This subtopic examines how PPAR ligands inhibit vascular inflammatory gene responses by antagonizing NF-κB and AP-1 transcription factors (Delerive et al., 1999, 1066 citations). PPARγ activation reduces atherosclerosis development in LDL receptor-deficient mice by modulating macrophage phenotypes (Li et al., 2000, 840 citations). Over 10 key papers from 1999-2011, with 5820+ total citations, link PPARs to chronic inflammation in fat and insulin resistance (Xu et al., 2003).

Curated Papers

Key Challenges

Why It Matters

PPAR ligands lower IL-6 levels in atherosclerosis models, offering therapeutic potential for metabolic-inflammatory diseases (Delerive et al., 1999). In obesity, chronic adipose inflammation drives insulin resistance, where PPAR modulation could restore metabolic homeostasis (Xu et al., 2003, 5820 citations). PPARγ agonists inhibit plaque formation in hyperlipidemic mice, supporting combo therapies targeting lipid metabolism and inflammation (Li et al., 2000). CD36-mediated lipid uptake in macrophages exacerbates atherosclerosis, with PPARs counteracting this via anti-inflammatory shifts (Febbraio et al., 2001, 1131 citations).

Key Research Challenges

NF-κB Cross-Talk Mechanisms

Dissecting precise molecular interactions between PPARs and NF-κB remains incomplete, complicating ligand design. Delerive et al. (1999) showed PPARα fibrates repress IL-6 via this pathway, but isoform-specific effects vary. Quantitative models of inhibition kinetics are needed for translation.

Macrophage Phenotype Dynamics

Balancing M1/M2 polarization in vivo under PPAR activation faces context-dependent reversals. Li et al. (2000) demonstrated PPARγ reduces atherosclerosis via M2 shifts in mice. Heterogeneity across tissues like fat and vessels requires single-cell resolution.

Ligand Specificity in Disease

Developing isoform-selective agonists without metabolic side effects challenges clinical use. Xu et al. (2003) linked fat inflammation to insulin resistance, where PPARδ/γ roles overlap. Clinical trials must address off-target effects on lipid metabolism (Rakhshandehroo et al., 2010).

Essential Papers

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Haiyan Xu, Glenn T. Barnes, Qing Yang et al. · 2003 · Journal of Clinical Investigation · 5.8K citations

Insulin resistance arises from the inability of insulin to act normally in regulating nutrient metabolism in peripheral tissues. Increasing evidence from human population studies and animal researc...

Prostaglandins and Inflammation

Emanuela Ricciotti, Garret A. FitzGerald · 2011 · Arteriosclerosis Thrombosis and Vascular Biology · 3.6K citations

Prostaglandins are lipid autacoids derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. They are generated ...

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

Maria Febbraio, David P. Hajjar, Roy L. Silverstein · 2001 · Journal of Clinical Investigation · 1.1K citations

Multiligand receptorsCD36, identified more than a quarter of a century ago as a platelet integral membrane glycoprotein (glycoprotein IV), was until recently best known as a receptor for thrombospo...

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

Philippe Delerive, Karolien De Bosscher, Sandrine Besnard et al. · 1999 · Journal of Biological Chemistry · 1.1K citations

Interleukin-6 (IL-6) is a pleiotropic cytokine, whose plasma levels are elevated in inflammatory diseases such as atherosclerosis. We have previously reported that peroxisome proliferator-activated...

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

Maryam Rakhshandehroo, Bianca Knoch, Michael Müller et al. · 2010 · PPAR Research · 991 citations

The peroxisome proliferator-activated receptor alpha (PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>α</mml:mi></mml:math>) is a ligand-activated transcription factor involved...

Sorting out the roles of PPAR in energy metabolism and vascular homeostasis

Philippe Lefèbvre · 2006 · Journal of Clinical Investigation · 934 citations

PPARalpha is a nuclear receptor that regulates liver and skeletal muscle lipid metabolism as well as glucose homeostasis. Acting as a molecular sensor of endogenous fatty acids (FAs) and their deri...

Lipid metabolism and cancer

Xueli Bian, Rui Liu, Ying Meng et al. · 2020 · The Journal of Experimental Medicine · 913 citations

Dysregulation in lipid metabolism is among the most prominent metabolic alterations in cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological membranes, and signa...

Reading Guide

Foundational Papers

Start with Delerive et al. (1999) for PPARα-NF-κB mechanism; Xu et al. (2003) for obesity inflammation links; Li et al. (2000) for PPARγ macrophage effects in vivo.

Recent Advances

Rakhshandehroo et al. (2010) on PPARα targets; Ricciotti and FitzGerald (2011) on prostaglandins tying to PPAR pathways.

Core Methods

Ligand activation assays, NF-κB reporter gene repression, LDLR-/- mouse atherosclerosis models, qPCR for cytokine/M2 markers like Arg1.

How PapersFlow Helps You Research PPARs in Inflammation and Macrophage Polarization

Discover & Search

Research Agent uses citationGraph on Delerive et al. (1999) to map PPAR-NF-κB papers, then findSimilarPapers reveals 50+ works on macrophage polarization like Xu et al. (2003). exaSearch queries 'PPARγ M2 polarization atherosclerosis' for 250M+ OpenAlex papers linking to obesity models.

Analyze & Verify

Analysis Agent applies readPaperContent to extract NF-κB suppression data from Delerive et al. (1999), then verifyResponse with CoVe checks claims against Li et al. (2000). runPythonAnalysis processes cytokine expression datasets with pandas for statistical verification; GRADE assigns high evidence to PPARα anti-inflammatory effects.

Synthesize & Write

Synthesis Agent detects gaps in isoform-specific polarization data across papers, flagging contradictions between PPARα (Delerive et al., 1999) and PPARγ (Li et al., 2000). Writing Agent uses latexEditText for figure captions, latexSyncCitations to integrate 10+ refs, and latexCompile for polished reviews; exportMermaid visualizes PPAR signaling pathways.

Use Cases

"Extract cytokine data from PPAR inflammation papers and plot M1/M2 ratios"

Research Agent → searchPapers('PPAR NF-κB cytokines') → Analysis Agent → readPaperContent(Xu et al. 2003) → runPythonAnalysis(pandas plot of IL-6 levels vs. controls) → matplotlib figure of polarization shifts.

"Draft LaTeX review on PPARγ in atherosclerosis macrophage models"

Synthesis Agent → gap detection(Delerive 1999 + Li 2000) → Writing Agent → latexEditText(structure sections) → latexSyncCitations(10 refs) → latexCompile(PDF) → researcher gets camera-ready manuscript with NF-κB diagrams.

"Find code for PPAR ligand simulation in inflammation models"

Research Agent → paperExtractUrls(Febbraio 2001) → paperFindGithubRepo → githubRepoInspect → Code Discovery workflow → researcher gets runnable Python scripts modeling CD36-PPAR interactions.

Automated Workflows

Deep Research workflow scans 50+ papers from citationGraph(Delerive 1999), structures report on PPAR isoform roles in polarization with GRADE scores. DeepScan applies 7-step CoVe to verify Xu et al. (2003) inflammation claims against recent lipid metabolism links. Theorizer generates hypotheses on combo PPAR-CD36 therapies from Li et al. (2000) abstracts.

Try Doxa for PPARs in Inflammation and Macrophage Polarization Research

Frequently Asked Questions

What defines PPARs' role in inflammation?

PPARs suppress pro-inflammatory genes via NF-κB antagonism; PPARα ligands lower IL-6 in vascular cells (Delerive et al., 1999).

What methods study macrophage polarization?

Mouse models like LDLR-/- test PPARγ agonists for atherosclerosis reduction via M2 shifts (Li et al., 2000); in vitro assays measure cytokine repression.

What are key papers?

Xu et al. (2003, 5820 citations) on fat inflammation; Delerive et al. (1999, 1066 citations) on PPARα-NF-κB; Li et al. (2000, 840 citations) on PPARγ anti-atherosclerosis.